1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Earnings

Perrigo Delivering Opill Sales Within A Month, Launches ‘Energize’ Efficiency Project Immediately

 
• By Malcolm Spicer

Perrigo says 2024 results will be slowed by investment in companywide efficiency project including staff reductions. After Opill’s expected launch by late March, sales will be dilutive to earnings for the first year partly due to investments in the brand, primarily at retailers and online in Q2.

• Source: Shutterstock

Perrigo Company PLC doesn’t downplay the likely boost to its revenues from the pending launch of Opill as the first oral contraceptive available OTC in the US, but the consumer health products giant also isn’t underestimating challenges to its growth.

Perrigo says its 2024 results will be slowed by investment in a companywide overhaul including staff reductions and organizational streamlining.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

Complementary Medicine Move Paying Off For Galenica

 
• By Tom Gallen

Galenica's Swiss consumer health business Verfora is reaping the rewards of its expansion in the complementary medicine market with a solid showing in the first half of the year.

Subscription Plot Twist Featured In Herbalife’s ‘Next Chapter’ With Pro2col Digital Platform

 
• By Malcolm Spicer

More than 7,000 distributors started a beta iteration of Pro2col in July Platform’s availability to additional US distributors =is planned for October, when it will launch with a Herbalife brand name.

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By Tom Gallen

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

Church & Dwight’s Options For Vitamin Brands: Divest, Find Partner, Shrink Business

 
• By Malcolm Spicer

Divesting C&D’s vitamin business, says CEO Richard Dierker, is “probably the cleanest option” as brands remain a drag on earnings after second quarter.

More from Business

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By Tom Gallen

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

Church & Dwight’s Options For Vitamin Brands: Divest, Find Partner, Shrink Business

 
• By Malcolm Spicer

Divesting C&D’s vitamin business, says CEO Richard Dierker, is “probably the cleanest option” as brands remain a drag on earnings after second quarter.

Haleon Adds High Strength Vitamin D To UK Centrum Multivitamin Line

 
• By David Ridley

Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.